+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

From
Alopecia Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Alopecia Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Graft Versus Host Disease (GvHD) Treatment Market - Product Thumbnail Image

Graft Versus Host Disease (GvHD) Treatment Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors Market 2024-2028 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 136 Pages
  • Global
From
Sjogrens Syndrome Therapeutics Market 2024-2028 - Product Thumbnail Image

Sjogrens Syndrome Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 160 Pages
  • Global
From
Atopic Dermatitis Drugs Market 2024-2028 - Product Thumbnail Image

Atopic Dermatitis Drugs Market 2024-2028

  • Report
  • May 2024
  • 175 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market 2024-2028 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 174 Pages
  • Global
From
Allergy Immunotherapies Market 2024-2028 - Product Thumbnail Image

Allergy Immunotherapies Market 2024-2028

  • Report
  • May 2024
  • 167 Pages
  • Global
From
Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market 2024-2028 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 145 Pages
  • Global
From
Human Immunoglobulin Market 2024-2028 - Product Thumbnail Image

Human Immunoglobulin Market 2024-2028

  • Report
  • August 2024
  • 215 Pages
  • Global
From
Uveitis Drugs Market 2024-2028 - Product Thumbnail Image

Uveitis Drugs Market 2024-2028

  • Report
  • August 2024
  • 143 Pages
  • Global
From
Hereditary Angioedema (HAE) Therapeutics Market 2024-2028 - Product Thumbnail Image

Hereditary Angioedema (HAE) Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 161 Pages
  • Global
From
Topical Corticosteroids Market 2024-2028 - Product Thumbnail Image

Topical Corticosteroids Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
Autoimmune Drugs Market 2024-2028 - Product Thumbnail Image

Autoimmune Drugs Market 2024-2028

  • Report
  • July 2024
  • 185 Pages
  • Global
From
Primary Immunodeficiency Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Immunodeficiency Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 136 Pages
  • Global
From
Immunosuppressants Market 2024-2028 - Product Thumbnail Image

Immunosuppressants Market 2024-2028

  • Report
  • July 2024
  • 138 Pages
  • Global
From
Scleroderma Therapeutics Market 2024-2028 - Product Thumbnail Image

Scleroderma Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 130 Pages
  • Global
From
HIV Treatment Drugs Market in Africa 2024-2028 - Product Thumbnail Image

HIV Treatment Drugs Market in Africa 2024-2028

  • Report
  • July 2024
  • 162 Pages
  • Africa
From
HIV Drugs Market 2024-2028 - Product Thumbnail Image

HIV Drugs Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more